A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

The NHS has provided guidance on identifying flu symptoms, which can emerge very rapidly and include a sudden high ...

Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...

The preventive effects of nirsevimab against respiratory syncytial virus infection persisted for up to 12 months after ...

Data from multiple countries shows monoclonal antibody shots for respiratory syncytial virus (RSV) is keeping more babies out ...

Health officials report flu activity has increased following recent dips, with RSV circulating at low to medium levels ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

As the leaves begin to change and the temperature starts to cool, families are reminded of respiratory syncytial virus (RSV) ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the respiratory virus season. However, especially among young infants under six ...